PANITUMUMAB
UNII 6A901E312A

Substance Identification & Data

This profile provides standardized clinical and technical data for Panitumumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6A901E312A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 339177-26-3 and the RxNorm Concept ID (RxCUI) 263034. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6A901E312A

CAS Registry Number

339177-26-3

RxNorm Concept ID

263034

Detailed Substance Profile

Preferred Name

PANITUMUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

6A901E312A

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C1857

National Cancer Institute reference terminology for clinical and research data.

INN ID

8499

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

PP-83

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Panitumumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PANITUMUMAB

Common Names & Synonyms

IMMUNOGLOBULIN, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN MONOCLONAL ABX-EGF HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ABX-EGF LIGHT CHAIN, DIMER

IMMUNOGLOBULIN, HUMAN (ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) MONOCLONAL ANTIBODY (ABX-EGF)

PANITUMUMAB [EMA EPAR]

PANITUMUMAB [INN]

PANITUMUMAB [JAN]

PANITUMUMAB [MART.]

PANITUMUMAB [MI]

PANITUMUMAB [PURPLE BOOK CDER]

PANITUMUMAB [USAN]

PANITUMUMAB [VANDF]

PANITUMUMAB [WHO-DD]